Category Archives: Research and Medicine

Seattle Genetics Seeing Substantial Growth with Clay Siegall

On Monday, Seattle Genetics announced that they were increasing their public stock from $480 million to $552 million. Clay Siegall announced that he expected to continue grow and be able to work more the company’s drug pipe line as well … Continue reading

Leave a comment »